Recommendations for the diagnosis and treatment of the acute porphyrias

Annals of Internal Medicine

Volumn 142, Issue 6, 2005, Pages 439-450

  Anderson, Karl E ^b   Bloomer, Joseph R ^b   Bonkovsky, Herbert L ^b   Kushner, James P ^b   Pierach, Claus A ^b   Pimstone, Neville R ^b   Desnick, Robert J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINOLEVULINIC ACID; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CARISOPRODOL; CIMETIDINE; CLONAZEPAM; DANAZOL; DICLOFENAC; ERGOT ALKALOID; ESTROGEN; ETHCHLORVYNOL; GLUCOSE; GLUTETHIMIDE; GRISEOFULVIN; HEMATIN; HEME; INSULIN; MEPHENYTOIN; METOCLOPRAMIDE; PARACETAMOL; PORPHOBILINOGEN; PORPHYRIN; PRIMIDONE; PROGESTERONE; PYRAZINAMIDE; RANITIDINE; STREPTOMYCIN; UNINDEXED DRUG; VALPROIC ACID; HEMIN;

ABDOMINAL PAIN; ACUTE INTERMITTENT PORPHYRIA; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL FEATURE; CONSTIPATION; DIARRHEA; DNA DETERMINATION; DRUG USE; EARLY DIAGNOSIS; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GENE LOCUS; HUMAN; HYPERTENSION; INBORN ERROR OF METABOLISM; MEDLINE; NEUROPATHY; NON PROFIT ORGANIZATION; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT PLANNING; URINALYSIS; VOMITING; PATIENT EDUCATION;

EARLY DIAGNOSIS; HEMIN; HUMANS; PATIENT EDUCATION; PORPHYRIA, ACUTE INTERMITTENT; PROGNOSIS;

EID: 14844362079     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-6-200503150-00010     Document Type: Review

References (78)

1. Anderson K, Sassa S, Bishop D, Desnick R. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver C, Beaudet A, Sly W, Valle D, Childs B, Kinzler K, Vogelstein B, eds. Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001:2991-3062.
2. Bonkovsky HL, Barnard GF. Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology. Semin Liver Dis. 1998;18:57-65. [PMID: 9516679]
3. Bonkowsky HL, Tschudy DP, Collins A, Doherty J, Bossenmaier I, Cardinal R, et al. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A. 1971;68:2725-9. [PMID: 5288250]
4. Stein JA, Tschudy DP. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine (Baltimore). 1970;49:1-16. [PMID: 4907358]
5. Watson CJ, Pierach CA, Bossenmaier I, Cardinal R. Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias. Proc Natl Acad Sci U S A. 1977;74:2118-20. [PMID: 266732]
6. Watson CJ, Pierach CA, Bossenmaier I, Cardinal R. Use of hematin in the acute attack of the "inducible" hepatic prophyrias. Adv Intern Med. 1978;23: 265-86. [PMID: 343541]
7. Lamon JM, Frykholm BC, Hess RA, Tschudy DP. Hematin therapy for acute porphyria. Medicine (Baltimore). 1979;58:252-69. [PMID: 449661]
8. Pierach CA, Bossenmaier I, Cardinal R, Weimer M, Watson CJ. Hematin therapy in porphyric attacks. Klin Wochenschr. 1980;58:829-32. [PMID: 7453089]
9. Doss M, Verspohl F. The "glucose effect" in acute hepatic porphyrias and in experimental porphyria. Klin Wochenschr. 1981;59:727-35. [PMID: 7253546]
10. Pierach CA. Hematin therapy for the porphyric attack. Semin Liver Dis. 1982;2:125-31. [PMID: 6753162]
11. Doss M, Sixel-Dietrich F, Verspohl F. "Glucose effect" and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias. J Clin Chem Clin Biochem. 1985;23:505-13. [PMID: 4067519]
12. Herrick AL, McColl KE, Moore MR, Cook A, Goldberg A. Controlled trial of haem arginate in acute hepatic porphyria. Lancet. 1989;1:1295-7. [PMID: 2566827]
13. Kostrzewska E, Gregor A, Tarczyńska-Nosal S. Heme arginate (Normosang) in the treatment of attacks of acute hepatic porphyrias. Mater Med Pol. 1991;23: 259-62. [PMID: 1842231]
14. Armas R, Wolff C, Krause P, Chaná P, Parraguez A, Soto J. [The hepatic porphyrias: experience with 105 cases]. Rev Med Chil. 1992;120:259-66. [PMID: 1342477]
15. Kostrzewska E, Gregor A, Tarzhinska-Nosal S. [Organization and results of studies on acute hepatic porphyrias in Poland]. Gematol Transfuziol. 1992;37: 3-4. [PMID: 1295780]
16. Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attacks. Arch Intern Med. 1993;153:2004-8. [PMID: 8357285]
17. Nordmann Y, Deybach JC. [Acute attacks of hepatic porphyria: specific treatment with heme arginate]. Ann Med Interne (Paris). 1993;144:165-7. [PMID: 8368699]
18. Jeans JB, Savik K, Gross CR, Weimer MK, Bossenmaier IC, Pierach CA, et al. Mortality in patients with acute intermittent porphyria requiring hospitalization: a United States case series. Am J Med Genet. 1996;65:269-73. [PMID: 8923933]
19. Kostrzewska E, Gregor A. Acute hepatic porphyrias. Detection, prophylaxis and treatment. Mater Med Pol. 1996;28:5-7. [PMID: 9088118]
20. Morales Ortega X, Wolff Fernández C, Leal Ibarra T, Montaña Navarro N, Armas-Merino R. [Porphyric crisis: experience of 30 episodes]. Medicina (B Aires). 1999;59:23-7. [PMID: 10349114]
21. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat. 2003; 21:577-81. [PMID: 12754702]
22. Waldenstrom J. The porphyrias as inborn errors of metabolism. Am J Med. 1957;22:758-73. [PMID: 13410965]
23. Goldberg A. Acute intermittent porphyria: a study of 50 cases. Q J Med. 1959;28:183-209. [PMID: 13658350]
24. Mustajoki P, Koskelo P. Hereditary hepatic porphyrias in Finland. Acta Med Scand. 1976;200:171-8. [PMID: 970225]
25. Nordmann Y, Puy H. Human hereditary hepatic porphyrias. Clin Chim Acta. 2002;325:17-37. [PMID: 12367763]
26. Solis C, Martinez-Bermejo A, Naidich TP, Kaufmann WE, Astrin KH, Bishop DF, et al. Acute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias. Arch Neurol. 2004;61:1764-70. [PMID: 15534187]
27. Soonawalla ZF, Orug T, Badminton MN, Elder GH, Rhodes JM, Bramhall SR, et al. Liver transplantation as a cure for acute intermittent porphyria. Lancet. 2004;363:705-6. [PMID: 15001330]
28. Hift RJ, Meissner PN, Todd G, Kirby P, Bilsland D, Collins P, et al. Homozygous variegate porphyria: an evolving clinical syndrome. Postgrad Med J. 1993;69:781-6. [PMID: 8290408]
29. Nordmann Y, Grandchamp B, de Verneuil H, Phung L, Cartigny B, Fontaine G. Harderoporphyria: a variant hereditary coproporphyria. J Clin Invest. 1983;72:1139-49. [PMID: 6886003]
30. Stojeba N, Meyer C, Jeanpierre C, Perrot F, Hirth C, Pottecher T, et al. Recovery from a variegate porphyria by a liver transplantation. Liver Transpl. 2004;10:935-8. [PMID: 15237381]
31. Thunell S, Henrichson A, Floderus Y, Groth CG, Eriksson BG, Barkholt L, et al. Liver transplantation in a boy with acute porphyria due to aminolaevulinate dehydratase deficiency. Eur J Clin Chem Clin Biochem. 1992;30:599-606. [PMID: 1493152]
32. Ridley A. Porphyric neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral Neuropathy. vol. 2. Philadelphia: WB Saunders; 1975:942-55.
33. Stein JA, Curl FD, Valsamis M, Tschudy DP. Abnormal iron and water metabolism in acute intermittent porphyria with new morphologic findings. Am J Med. 1972;53:784-9. [PMID: 4634732]
34. Church SE, McColl KE, Moore MR, Youngs GR. Hypertension and renal impairment as complications of acute porphyria. Nephrol Dial Transplant. 1992; 7:986-90. [PMID: 1331893]
35. Ostrowski J, Kostrzewska E, Michalak T, Zawirska B, Medrzejewski W, Gregor A. Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias. Gastroenterology. 1983;85: 1131-7. [PMID: 6618105]
36. Lithner F, Wetterberg L. Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Med Scand. 1984;215:271-4. [PMID: 6328897]
37. Kauppinen R, Mustajoki P. Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer. 1988;57:117-20. [PMID: 2831925]
38. Andersson C, Bjersing L, Lithner F. The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med. 1996;240: 195-201. [PMID: 8918510]
39. Andant C, Puy H, Faivre J, Deybach JC. Acute hepatic porphyrias and primary liver cancer [Letter]. N Engl J Med. 1998;338:1853-4. [PMID: 9634374]
40. Linet MS, Gridley G, Nyrén O, Mellemkjaer L, Olsen JH, Keehn S, et al. Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden. Am J Epidemiol. 1999;149:1010-5. [PMID: 10355376]
41. Anderson KE, Spitz IM, Bardin CW, Kappas A. A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria. Arch Intern Med. 1990; 150:1469-74. [PMID: 2196028]
42. Lip GY, McColl KE, Goldberg A, Moore MR. Smoking and recurrent attacks of acute intermittent porphyria. BMJ. 1991;302:507. [PMID: 2012848]
43. Watson CJ, Schwanz S. A simple test for urinary porphobilinogen. Proc Soc Exp Biol Med. 1941;47:393-4.
44. Mauzerall D, Granick S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956;219:435-46. [PMID: 13295297]
45. Lamon J, With TK, Redeker AG. The Hoesch test: bedside screening for urinary porphobilinogen in patients with suspected porphyria. Clin Chem. 1974; 20:1438-40. [PMID: 4425514]
46. Deacon AC, Peters TJ. Identification of acute porphyria: evaluation of a commercial screening test for urinary porphobilinogen. Ann Clin Biochem. 1998;35 (Pt 6):726-32. [PMID: 9838985]
47. Poh-Fitzpatrick MB. A plasma porphyrin fluorescence marker for variegate porphyria. Arch Dermatol. 1980;116:543-7. [PMID: 7377785]
48. Hift RJ, Davidson BP, van der Hooft C, Meissner DM, Meissner PN. Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as a reference standard. Clin Chem. 2004;50:915-23. [PMID: 14976149]
49. Blake D, McManus J, Cronin V, Ratnaike S. Fecal coproporphyrin isomers in hereditary coproporphyria. Clin Chem. 1992;38:96-100. [PMID: 1733615]
50. Jacob K, Doss MO. Excretion pattern of faecal coproporphyrin isomers I-IV in human porphyrias. Eur J Clin Chem Clin Biochem. 1995;33:893-901. [PMID: 8845420]
51. Meissner PN, Dailey TA, Hift RJ, Ziman M, Corrigall AV, Roberts AG, et al. A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet. 1996;13:95-7. [PMID: 8673113]
52. Lee JS, Anvret M. Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria. Proc Natl Acad Sci U S A. 1991;88:10912-5. [PMID: 1961762]
53. Welland FH, Hellman ES, Gaddis EM, Collins G, Hunter GW Jr, Tschudy DP. Factors affecting the excretion of porphyrin precursors by patients with acute intermittent porphyria. I. The effect of diet. Metabolism. 1964;13: 232-50. [PMID: 14127691]
54. Felsher BF, Redeker AG. Acute intermittent porphyria: effect of diet and griseofulvin. Medicine (Baltimore). 1967;46:217-23. [PMID: 6027463]
55. Rose JA, Hellman ES, Tschudy DP. Effect of diet on induction of experimental porphyria. Metabolism. 1961;10:514-21. [PMID: 13743276]
56. Tschudy DP, Welland FH, Collins A, Hunter G Jr. The effect of carbohydrate feeding on the induction of delta-aminolevulinic acid synthetase. Metabolism. 1964;13:396-406. [PMID: 14169218]
57. Tschudy DP, Valsamis M, Magnussen CR. Acute intermittent porphyria: clinical and selected research aspects. Ann Intern Med. 1975;83:851-64. [PMID: 1106284]
58. McColl KE, Moore MR, Thompson GG, Goldberg A. Treatment with haematin in acute hepatic porphyria. Q J Med. 1981;50:161-74. [PMID: 7302116]
59. Mustajoki P, Tenhunen R, Tokola O, Gothoni G. Haem arginate in the treatment of acute hepatic porphyrias. Br Med J (Clin Res Ed). 1986;293:538-9. [PMID: 3092906]
60. Bonkovsky HL, Healey JF, Lourie AN, Gerron GG. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am J Gastroenterol. 1991;86:1050-6. [PMID: 1713408]
61. Pierach CA. Haem and porphyria attacks [Letter]. Lancet. 1989;2:213-4. [PMID: 2568536]
62. Tenhunen R, Mustajoki P. Acute porphyria: treatment with heme. Semin Liver Dis. 1998;18:53-5. [PMID: 9516678]
63. Elder GH, Hift RJ, Meissner PN. The acute porphyrias. Lancet. 1997;349: 1613-7. [PMID: 9174571]
64. Thadani H, Deacon A, Peters T. Diagnosis and management of porphyria. BMJ. 2000;320:1647-51. [PMID: 10856069]
65. Anderson KE. Approaches to treatment and prevention of human porphyrias. In: Kadish K, Smith K, Guilard R, eds. The Porphyrin Handbook. Medical Aspects of Porphyrins. vol. 14. San Diego, CA: Academic Pr, Elsevier Science; 2003:247-83.
66. Wilson J, de Rooij F. Management and treatment of the porphyrias. In: Kadish KM, Smith KM, Guilard R, eds. Porphyrin Handbook. Medical Aspects of Porphyrins. vol. 14. San Diego: Academic Pr; 2003:285-302.
67. Green D, Reynolds N, Klein J, Kohl H, Ts'ao CH. The inactivation of hemostatic factors by hematin. J Lab Clin Med. 1983;102:361-9. [PMID: 6411843]
68. Goetsch CA, Bissell DM. Instability of hematin used in the treatment of acute hepatic porphyria. N Engl J Med. 1986;315:235-8. [PMID: 3724815]
69. Green D, Furby FH, Berndt MC. The interaction of the factor VIII/von Willebrand factor complex with hematin. Thromb Haemost. 1986;56:277-82. [PMID: 3105105]
70. Jones RL. Hematin-derived anticoagulant. Generation in vitro and in vivo. J Exp Med. 1986;163:724-39. [PMID: 3950544]
71. Green D, Ts'ao CH. Hematin: effects on hemostasis. J Lab Clin Med. 1990;115:144-7. [PMID: 2405084]
72. Khanderia U. Circulatory collapse associated with hemin therapy for acute intermittent porphyria. Clin Pharm. 1986;5:690-2. [PMID: 3742954]
73. Dhar GJ, Bossenmaier I, Cardinal R, Petryka ZJ, Watson CJ. Transitory renal failure following rapid administration of a relatively large amount of hematin in a patient with acute intermittent porphyria in clinical remission. Acta Med Scand. 1978;203:437-43. [PMID: 665312]
74. Kauppinen R, Mustajoki P. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine (Baltimore). 1992;71:1-13. [PMID: 1549056]
75. Milo R, Neuman M, Klein C, Caspi E, Arlazoroff A. Acute intermittent porphyria in pregnancy. Obstet Gynecol. 1989;73:450-2. [PMID: 2915870]
76. Shenhav S, Gemer O, Sassoon E, Segal S. Acute intermittent porphyria precipitated by hyperemesis and metoclopramide treatment in pregnancy. Acta Obstet Gynecol Scand. 1997;76:484-5. [PMID: 9197454]
77. Lamon JM, Frykholm BC, Bennett M, Tschudy DP. Prevention of acute porphyric attacks by intravenous haematin. Lancet. 1978;2:492-4. [PMID: 79864]
78. Kostrzewska E, Gregor A. [35 Years of effort to improve the diagnosis of porphyria]. Przegl Lek. 1999;56:576-8. [PMID: 10695362]